Free Trial

Avid Bioservices (CDMO) Competitors

$9.09
+0.01 (+0.11%)
(As of 05/22/2024 ET)

CDMO vs. HROW, OLMA, STOK, PHAT, CMPS, SIGA, ORIC, ALT, AVBP, and IGMS

Should you be buying Avid Bioservices stock or one of its competitors? The main competitors of Avid Bioservices include Harrow (HROW), Olema Pharmaceuticals (OLMA), Stoke Therapeutics (STOK), Phathom Pharmaceuticals (PHAT), COMPASS Pathways (CMPS), SIGA Technologies (SIGA), ORIC Pharmaceuticals (ORIC), Altimmune (ALT), ArriVent BioPharma (AVBP), and IGM Biosciences (IGMS). These companies are all part of the "pharmaceutical preparations" industry.

Avid Bioservices vs.

Avid Bioservices (NASDAQ:CDMO) and Harrow (NASDAQ:HROW) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

97.2% of Avid Bioservices shares are held by institutional investors. Comparatively, 72.8% of Harrow shares are held by institutional investors. 2.4% of Avid Bioservices shares are held by insiders. Comparatively, 13.7% of Harrow shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Avid Bioservices has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500. Comparatively, Harrow has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500.

Avid Bioservices has a net margin of -13.10% compared to Harrow's net margin of -22.59%. Avid Bioservices' return on equity of -8.78% beat Harrow's return on equity.

Company Net Margins Return on Equity Return on Assets
Avid Bioservices-13.10% -8.78% -3.61%
Harrow -22.59%-39.82%-8.13%

Avid Bioservices has higher revenue and earnings than Harrow. Avid Bioservices is trading at a lower price-to-earnings ratio than Harrow, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avid Bioservices$149.27M3.87$260K-$0.27-33.67
Harrow$130.19M4.68-$24.41M-$0.91-18.92

Avid Bioservices currently has a consensus target price of $14.50, suggesting a potential upside of 59.52%. Harrow has a consensus target price of $29.80, suggesting a potential upside of 73.05%. Given Harrow's stronger consensus rating and higher probable upside, analysts plainly believe Harrow is more favorable than Avid Bioservices.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avid Bioservices
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
Harrow
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Avid Bioservices received 286 more outperform votes than Harrow when rated by MarketBeat users. Likewise, 66.49% of users gave Avid Bioservices an outperform vote while only 56.25% of users gave Harrow an outperform vote.

CompanyUnderperformOutperform
Avid BioservicesOutperform Votes
367
66.49%
Underperform Votes
185
33.51%
HarrowOutperform Votes
81
56.25%
Underperform Votes
63
43.75%

In the previous week, Harrow had 6 more articles in the media than Avid Bioservices. MarketBeat recorded 14 mentions for Harrow and 8 mentions for Avid Bioservices. Avid Bioservices' average media sentiment score of 0.80 beat Harrow's score of 0.39 indicating that Avid Bioservices is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avid Bioservices
3 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Harrow
2 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Avid Bioservices beats Harrow on 12 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDMO vs. The Competition

MetricAvid BioservicesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$577.03M$6.53B$5.07B$8.01B
Dividend YieldN/A2.71%2.81%3.92%
P/E Ratio-33.6715.95154.0917.11
Price / Sales3.87399.932,531.6193.38
Price / Cash60.1735.9635.6232.25
Price / Book3.015.555.454.62
Net Income$260,000.00$97.29M$104.88M$214.11M
7 Day Performance-1.73%0.38%0.24%0.10%
1 Month Performance41.81%4.89%4.12%5.04%
1 Year Performance-40.67%-5.87%5.20%8.43%

Avid Bioservices Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HROW
Harrow
2.8704 of 5 stars
$16.24
+34.5%
$28.13
+73.2%
-22.7%$574.57M$130.19M-21.65182Gap Up
High Trading Volume
OLMA
Olema Pharmaceuticals
1.9904 of 5 stars
$10.17
+10.3%
$21.67
+113.0%
+47.6%$568.81MN/A-5.0374
STOK
Stoke Therapeutics
3.6632 of 5 stars
$12.80
+10.8%
$20.57
+60.7%
+39.9%$601.99M$7.84M-5.31110
PHAT
Phathom Pharmaceuticals
2.2325 of 5 stars
$10.39
+7.4%
$22.00
+111.7%
-23.2%$608.13M$680,000.00-2.36452
CMPS
COMPASS Pathways
1.6523 of 5 stars
$8.17
+0.6%
$47.40
+480.2%
-5.9%$558.67MN/A-3.45186
SIGA
SIGA Technologies
0.1885 of 5 stars
$7.85
+5.4%
N/A+33.6%$558.29M$139.92M7.1445
ORIC
ORIC Pharmaceuticals
3.9897 of 5 stars
$9.09
+1.3%
$20.00
+120.0%
+75.3%$612.85MN/A-5.05100
ALT
Altimmune
0.9682 of 5 stars
$7.82
+6.1%
$17.25
+120.6%
+76.1%$554.44M$430,000.00-4.9259Gap Up
AVBP
ArriVent BioPharma
1.1729 of 5 stars
$18.46
+3.0%
$29.25
+58.5%
N/A$618.23MN/A0.0040Positive News
IGMS
IGM Biosciences
3.671 of 5 stars
$9.20
-0.8%
$17.89
+94.4%
-6.1%$540.87M$2.13M-2.13224News Coverage
Gap Up

Related Companies and Tools

This page (NASDAQ:CDMO) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners